MDVX Insider Trading Activity and SEC Form 4 Filings
MDVX insider trading summary
No open-market insider purchases or sales of Medovex Corp. (MDVX) have been reported on SEC Form 4 in the past 12 months.
Latest MDVX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 15, 2017 | Jon Mogford | Director | Buy | $700 (1,000 @ $0.70) |
| Dec 15, 2017 | John C Thomas | Director | Buy | $4K (6,000 @ $0.70) |
| Sep 19, 2017 | Scott Haufe | Insider | Sell | $24K (20,000 @ $1.18) |
| Sep 18, 2017 | Scott Haufe | Insider | Sell | $60K (50,000 @ $1.19) |
| Aug 21, 2017 | Steve Gorlin | Insider | Buy | $63K (50,000 @ $1.25) |
| Aug 16, 2017 | Steve Gorlin | Insider | Buy | $180K (200,000 @ $0.90) |
| Jul 14, 2017 | Randal R Betz | Insider | Buy | $10K (10,989 @ $0.91) |
| Jun 28, 2017 | Steve Gorlin | Insider | Buy | $3K (3,000 @ $0.87) |
| Jun 28, 2017 | Steve Gorlin | Insider | Buy | $2K (2,000 @ $0.88) |
| Jun 19, 2017 | Jarrett S Gorlin | Chief Executive Officer | Buy | $18K (20,000 @ $0.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.